About TBG Diagnostics
TBG Diagnostics is a company based in Darra (Australia) founded in 1989.. TBG Diagnostics has completed 1 acquisition, including CellGate. TBG Diagnostics offers products and services including Reagents, QzTGSO, Nanopore, QzNGS, and Illumina. TBG Diagnostics operates in a competitive market with competitors including HYCOR BioMedical, Exagen, Lophius Biosciences, PredictImmune and Immudex, among others.
- Headquarter Darra, Australia
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TBG Diagnostics
TBG Diagnostics offers a comprehensive portfolio of products and services, including Reagents, QzTGSO, Nanopore, QzNGS, and Illumina. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Essential chemicals for laboratory experiments
Tools for advanced DNA sequencing applications
Systems for real-time genetic analysis
Solutions for next-generation sequencing
Platforms for high-throughput sequencing
Services for HLA typing and assurance
Techniques for sequence-based typing
Probes for targeted genetic detection
Quantitative PCR for gene expression
Automated systems for sample processing
Services for streamlining scientific workflows
Funding Insights of TBG Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by TBG Diagnostics
TBG Diagnostics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CellGate. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Oncology drugs were developed by CellGate until its 2008 acquisition.
|
1998 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - TBG Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tbg Diagnostics Comparisons
Competitors of TBG Diagnostics
TBG Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HYCOR BioMedical, Exagen, Lophius Biosciences, PredictImmune and Immudex, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of diagnostic instruments and reagents for autoimmune diseases and allergies
|
|
| domain | founded_year | HQ Location |
Diagnostic and monitoring solutions for autoimmune connective diseases are developed.
|
|
| domain | founded_year | HQ Location |
T-cell-based diagnostics for infectious and immune diseases are developed.
|
|
| domain | founded_year | HQ Location |
Tools for diagnosing immune-mediated inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Provider of immune monitoring reagents and services for research and clinical use
|
|
| domain | founded_year | HQ Location |
Diagnostic biomarker tests for inflammation and autoimmune diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tbg Diagnostics
Frequently Asked Questions about TBG Diagnostics
When was TBG Diagnostics founded?
TBG Diagnostics was founded in 1989.
Where is TBG Diagnostics located?
TBG Diagnostics is headquartered in Darra, Australia. It is registered at Darra, Queensland, Australia.
What does TBG Diagnostics do?
TBG Diagnostics was founded in 1989 in Darra, Australia, and operates within the molecular diagnostics sector. Kits, instruments, and software for applications such as HLA typing and DNA extraction are developed and manufactured. Products include automated multichannel pipettes and gel electrophoresis instruments. Progen Pharmaceuticals was acquired in January 2016, followed by RBC Biosciences in August 2016. Majority ownership is held by Medigen Biotechnology Corp of Taiwan.
Who are the top competitors of TBG Diagnostics?
TBG Diagnostics's top competitors include Exagen, SmartHealth and HYCOR BioMedical.
What products or services does TBG Diagnostics offer?
TBG Diagnostics offers Reagents, QzTGSO, Nanopore, QzNGS, and 6 more products and services.
How many acquisitions has TBG Diagnostics made?
TBG Diagnostics has made 1 acquisition, including CellGate.